Variant report
Variant | nsv1031276 |
---|---|
Chromosome Location | chr7:4396732-4437493 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:4419960..4422829-chr7:4435237..4437889,2 | MCF-7 | breast: | |
2 | chr7:4401235..4402088-chr7:4518606..4519411,2 | MCF-7 | breast: | |
3 | chr7:4398858..4401827-chr7:4402346..4405270,2 | MCF-7 | breast: | |
4 | chr7:4398858..4401827-chr7:4402346..4405270,2 | MCF-7 | breast: | |
5 | chr7:4419960..4422829-chr7:4435237..4437889,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17134723 | chr7:4397607-4397608 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539109444 | chr7:4397610-4397611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558815168 | chr7:4397643-4397644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138720983 | chr7:4397650-4397651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558899671 | chr7:4397661-4397662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148835120 | chr7:4397668-4397669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76651821 | chr7:4397678-4397679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4720252 | chr7:4397694-4397695 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs563196918 | chr7:4397703-4397704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143446928 | chr7:4397710-4397711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368642359 | chr7:4397772-4397773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11980884 | chr7:4397784-4397785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11973961 | chr7:4397785-4397786 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs147973275 | chr7:4397798-4397799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11973962 | chr7:4397799-4397800 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs547920717 | chr7:4397806-4397807 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11973979 | chr7:4397843-4397844 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs188509880 | chr7:4397853-4397854 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550519170 | chr7:4397857-4397858 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570243201 | chr7:4397918-4397919 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11973995 | chr7:4397928-4397929 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs117386030 | chr7:4397935-4397936 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567476575 | chr7:4397944-4397945 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11980932 | chr7:4397959-4397960 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535122252 | chr7:4397970-4397971 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141795339 | chr7:4397982-4397983 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531606311 | chr7:4397991-4397992 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146025760 | chr7:4398003-4398004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4720253 | chr7:4398027-4398028 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
30 | rs556864235 | chr7:4398031-4398032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576612869 | chr7:4398084-4398085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545719047 | chr7:4398137-4398138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559393700 | chr7:4398140-4398141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572800984 | chr7:4398151-4398152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138698597 | chr7:4398176-4398177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561632147 | chr7:4398177-4398178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530552212 | chr7:4398190-4398191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141739283 | chr7:4398200-4398201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35690655 | chr7:4403004-4403005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139382679 | chr7:4403057-4403058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112096931 | chr7:4403062-4403063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs367664319 | chr7:4403110-4403111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181303582 | chr7:4403165-4403166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546946091 | chr7:4403170-4403171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566656433 | chr7:4403210-4403211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116775718 | chr7:4403232-4403233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549099008 | chr7:4403245-4403246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537773115 | chr7:4403261-4403262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73311911 | chr7:4403287-4403288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184802350 | chr7:4403369-4403370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Chordoma | 21602918 | CNVD |
Lynch syndrome | 22585707 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Breast cancer | 16397240 | CNVD |
Raine Syndrome | 17924334 | CNVD |
Diffuse large b-cell lymphoma | 21266526 | CNVD |
Melanoma | 18172304 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 18556773 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Mental retardation | 17901693 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:4397600-4398000 | Enhancers | Fetal Muscle Trunk | muscle |
2 | chr7:4397600-4398200 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr7:4397800-4398000 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr7:4403000-4403600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr7:4403600-4404400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr7:4404400-4406600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr7:4406600-4407200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr7:4408000-4410200 | Weak transcription | Aorta | Aorta |
9 | chr7:4410200-4410800 | ZNF genes & repeats | Aorta | Aorta |
10 | chr7:4410400-4410800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr7:4425800-4426200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |